What are the management options for a patient with mesh placement recurrence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Mesh Placement Recurrence

For patients with hernia recurrence after mesh placement, the optimal management strategy depends on whether infection is present: if no infection exists, proceed with re-repair using synthetic mesh in clean fields or biological mesh in contaminated fields; if infection is present, complete mesh explantation is mandatory followed by delayed definitive repair after infection resolution. 1

Initial Assessment: Distinguish Infection from Recurrence

The first critical step is determining whether the recurrence involves mesh infection, as this fundamentally alters management:

  • Deep mesh infections present with indolent, chronic signs and symptoms that are frequently underestimated, including local inflammation, drainage, or sinus tract formation 1, 2
  • Superficial wound infections occur early postoperatively with localized inflammation and pain at the incision site, and do not necessarily indicate deep mesh involvement 1, 2
  • CT imaging is the gold standard for evaluating mesh-related complications, assessing for fluid collections, abscess formation, and mesh position 2
  • Wound cultures should be obtained if drainage is present to guide antibiotic therapy 2

Management Algorithm for Infected Mesh with Recurrence

Conservative Management (Limited Role)

  • Conservative non-surgical management with antibiotics and mechanical scrubbing/irrigation to remove biofilm can be attempted in select cases of early infection 1
  • Early antibiotics and mechanical irrigation are important before biofilm consolidates, as biofilm provides bacteria an effective barrier against host immune cells and antibiotics 1

Surgical Management (Definitive Treatment)

Complete surgical removal of the infected mesh is recommended to reduce the risk of infection recurrence or severe complications such as visceral adhesions and fistulae 1, 2:

  • Conservative surgical approaches including abscess drainage, sinus excision, or partial mesh excision frequently fail and result in recurrent mesh infections 1
  • 72.7% of mesh infections ultimately require mesh explantation 1
  • Predictors of mesh explantation include type of mesh (OR 3.13), onlay position (OR 3.51), and associated enterotomy (OR 5.17) 1

Post-Explantation Wound Management

  • Leave the wound open for drainage if infection was present 2
  • Negative pressure wound therapy should be considered for larger wounds once infection is controlled 2
  • Surgical debridement must remove all necrotic or devitalized tissue 2

Delayed Definitive Repair Options

After complete infection resolution (typically 3-6 months), plan delayed hernia repair 2:

For clean/clean-contaminated fields (CDC class I-II):

  • Synthetic mesh is preferred as it provides superior long-term outcomes with significantly lower recurrence rates (9%) compared to tissue repair (19%) 3, 2, 4
  • Laparoscopic approaches (TAPP or TEP) offer advantages including lower wound infection rates 3

For contaminated/dirty fields (CDC class III-IV):

  • Small defects (<3 cm): Primary repair without mesh 3, 4
  • Larger defects (≥3 cm): Biological mesh is preferred when available 3, 2, 4
  • Non-cross-linked biological mesh can be used without subsequent mesh infection and need for explantation 1, 2
  • If biological mesh unavailable: Consider polyglactin mesh or open wound management with delayed repair 3

Management Algorithm for Non-Infected Recurrence

Assess Surgical Field Classification

Clean or clean-contaminated fields:

  • Synthetic mesh repair should be performed regardless of defect size, as this provides significantly lower recurrence rates 3, 4
  • No increased 30-day wound-related morbidity has been observed with mesh use in clean-contaminated fields 3, 4

Contaminated or dirty fields:

  • Defects <3 cm: Primary repair without mesh 3, 4
  • Defects ≥3 cm: Biological mesh preferred 3, 4

Optimal Mesh Positioning

Underlay or retrorectus mesh placement is associated with lower recurrence rates compared to onlay or interposition positioning 5:

  • Onlay position has highest recurrence rates (17%) and is an independent predictor of mesh explantation (OR 3.51) 1, 5
  • Retrorectus repair has lowest seroma rates (4%) 5
  • Underlay positioning demonstrates superior outcomes with lower recurrence rates 5

Critical Pitfalls to Avoid

  • Never attempt mesh placement in the presence of active infection, as this will lead to mesh infection requiring removal 2
  • Never perform partial mesh excision as the primary approach for deep infection, as this frequently fails and results in recurrent infections 1, 2
  • Never close infected wounds primarily, as this traps bacteria and worsens the infection 2
  • Never delay surgical drainage if purulent material is present, as antibiotics alone are insufficient 2
  • Never underestimate chronic, indolent presentations of deep mesh infection 1, 2
  • Do not avoid mesh in clean/clean-contaminated fields due to fear of infection, as evidence shows it is safe and significantly reduces recurrence 4

Expected Outcomes

  • High likelihood of hernia recurrence (15-20%) is expected after mesh removal without re-repair 2
  • Recurrence rates with appropriate mesh repair: 9% for synthetic mesh in clean/clean-contaminated fields, 30% for biological mesh in contaminated fields 1
  • Recurrence rates depend on achieving primary fascial closure: Biological mesh sublay repair with primary fascial closure shows lower recurrence rates than bridging repairs 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Abdominal Pain Surrounding Hernial Mesh Implant

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hernioplasty Approach Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Mesh Use in Incarcerated Hernia Repair

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.